Phadezym Ige Prist Test
510(k) K810507
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK810507 | Date20 Mar 1981 | StatusActive |
Recalls
No FDA recalls found in the data synced 6 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- DGC
- Device Class
- Class II
- Regulation
- 21 CFR Part 866.5510
- Advisory Committee
- Immunology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 22 Sep 2026
The Phadezym Ige Prist Test is an immunology device categorized as an IgE, antigen, antiserum, and control. It is designed for use in clinical laboratory settings to assist in the detection and measurement of immunoglobulin E.
This device is manufactured by Pharmacia, Inc. and has received FDA 510(k) clearance under the product code DGC. It is classified as a Class II medical device subject to special controls.
Other devices from Pharmacia, Inc.
Questions
AI-generated answers, 22 Sep 2026
What is the primary purpose of the Phadezym IgE PRIST Test?
This device is designed for use in clinical laboratory settings to assist healthcare professionals in the detection and measurement of immunoglobulin E (IgE) in patient samples.
What is the regulatory status of this device?
The Phadezym IgE PRIST Test is a Class II medical device that has received FDA 510(k) clearance under the product code DGC, indicating it has been found substantially equivalent to legally marketed predicate devices.
Which medical specialty is this test associated with?
This device is categorized under the immunology medical specialty, as it is used to identify and quantify specific immunological components, specifically IgE, antigens, antisera, and controls.